Quest Diagnostics (DGX) New Pact to Boost Laboratory Services

04:17pm, Wednesday, 15'th Feb 2023 Zacks Investment Research
Quest Diagnostics' (DGX) recent agreement is intended to offer advanced and quality clinical laboratory services in the greater New York region and beyond.

2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7%

01:53pm, Wednesday, 15'th Feb 2023 The Motley Fool
These companies may not be finished raising their dividend payments as they both have low payout ratios.
Quest Diagnostics' (DGX) recent agreement is intended to offer advanced and quality clinical laboratory services in the greater New York region and beyond.

3 MedTech Stocks Likely to Beat Estimates This Earnings Season

12:42pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EXAS, MDT and IART are poised ahead of their earnings releases.
The World Health Organization said nearly 20 million new COVID cases were recorded in the 28 days through Jan. 29, down 78% from the previous 28 days.

Quest Diagnostics (DGX) Q4 Earnings Top Estimates, Margin Down

06:58pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Improvement within Quest Diagnostics' (DGX) legacy base business contributes to Q4 performance.
Improvement within Quest Diagnostics' (DGX) legacy base business contributes to Q4 performance.

Quest Diagnostics (DGX) Beats Q4 Earnings and Revenue Estimates

01:05pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.21% and 3.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics Incorporated (NYSE:DGX ) Q4 2022 Earnings Conference Call February 2, 2023 8:30 AM ET Company Participants Jim Davis - President, Chief Executive Officer Sam Samad - Executive Vice P
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 4.21% and 3.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Quest Diagnostics Inc. DGX, +0.11% posted net income of $101 million, or 87 cents a share, for the fourth quarter, down from $390 million, or $3.12 a share, in the year-earlier period. Adjusted per-sh
Quest Diagnostics Inc. DGX, +0.11% said Thursday its board has agreed to raise its quarterly dividend by 7.6% to 71 cents a share. The new dividend will be payable April 24 to shareholders of record a

MedTech Stocks' Earnings to Watch on Feb 2: BDX, DGX & CNMD

02:07pm, Wednesday, 01'st Feb 2023 Zacks Investment Research
Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat staffing challenges. Let's see how BDX, DGX and CNMD are likely to fare this time.
There is a slew of dividend increases coming in February, including from dividend kings Genuine Parts, 3M, and PepsiCo in the first half of the month. Other popular stocks that traditionally announce
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE